Who won the Hims vs. Novo feud?
Novo Nordisk and Hims appear to have buried the hatchet. Hims & Hers is going to sell the…
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Novo Nordisk A/S Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving…
Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies
By Blake Brittain Feb 10 (Reuters) – Novo Nordisk’s U.S. patent lawsuit against Hims & Hers, filed on…
Novo Nordisk’s Legal Battle Over Wegovy Compounded Versions
Novo Nordisk’s Patent Lawsuit Overview By Blake Brittain Background of the Case Feb 10 (Reuters) – Novo Nordisk’s…
Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash
By Stine Jacobsen and Maggie Fick COPENHAGEN, Feb 9 (Reuters) – Novo Nordisk sued Hims and Hers Health…
Novo Nordisk threatens legal action over Hims Wegovy copy
Listen to this article The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of…